PUBLISHER: Grand View Research | PRODUCT CODE: 1726399
PUBLISHER: Grand View Research | PRODUCT CODE: 1726399
The global non-invasive intracranial pressure monitoring devices market size is anticipated to reach USD 478.1 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2025 to 2030. Increasing incidences of neurological diseases, coupled with a subsequent rise in the number of surgical procedures to treat associated conditions, are driving the market.
Non-invasive intracranial pressure monitoring devices are used to measure the pressure within the skull caused by trauma or medical conditions, such as intracranial hypertension, hydrocephalus, subarachnoid hemorrhages, inflammatory diseases, and cerebrospinal space diseases. These devices help in monitoring the pressure, as increased Intracranial Pressure (ICP) can result in serious or life-threatening medical problems.
Moreover, the high incidence rate of traumatic brain injuries due to road accidents and sports incidents is anticipated to boost the demand for non-invasive intracranial pressure monitoring devices. For instance, globally, in 2020 alone, around 11 million individuals are estimated to be affected by Traumatic Brain Injuries (TBIs).
Additionally, key players are adopting various strategies, such as M&A, partnerships, and product launches, to strengthen their foothold in the market. For instance, in November 2019, Raumedic AG introduced the ICP monitoring device for home use, which is intended for the diagnosis of people who suffer from hydrocephalus.